Marion B Naff

Title: The Innovative Contributions of Marion B Naff

Introduction

Marion B Naff is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 2 patents, his work has had a profound impact on cancer treatment.

Latest Patents

One of Naff's latest patents involves the compound N-Phosphonacetyl-L-aspartato(1,2-diaminocyclohexane)platinum(II). This compound has demonstrated antitumor activity against various types of tumors, including murine leukemia L1210, B-16, Colon 38 tumors, and Ehrlich ascites tumor. The effective dosages range from 5-60 mg/kg of body weight, and it shows enhanced efficacy when used in combination with cyclophosphamide and hydroxyurea. The compound can also be used in a binary treatment regimen with cisplatin, with a preferred ratio of about 10:1.

Career Highlights

Naff's career is marked by his association with the United States of America as represented by the Department of Health. His innovative work in developing platinum-based compounds has opened new avenues for cancer treatment and has contributed to the advancement of medical science.

Collaborations

Some of Naff's notable coworkers include Sandra J Meischen and Glen R Gale, who have collaborated with him on various research projects.

Conclusion

Marion B Naff's contributions to the field of pharmaceuticals, particularly in cancer treatment, highlight his role as an influential inventor. His innovative compounds continue to pave the way for advancements in medical therapies.